ORIGINAL RESEARCH
Accepted on 24 Jun 2025
Postoperative Hepatitis B Virus Reactivation and Its Impact on Survival in HBV-Related Hepatocellular Carcinoma Patients Undergoing Conversion Therapy with Interventional Therapy Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
doi 10.3389/fcimb.2025.1598193